Eris Lifesciences Limited has informed the Exchange about Transcript
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has informed the stock exchanges that the transcript of its Analyst and Investor conference call held after the Q1FY26 (quarter ended June 30, 2025) results is now available on the company's website. The transcript can be accessed at eris.co.in/financials under the file 'Transcript of the Analyst and Investor Conference call Q1FY26'. The filing was signed by Milind Talegaonkar, Company Secretary, on August 11, 2025. The actual content of the call is not included in this exchange filing itself.
This is a routine compliance disclosure with no direct impact on the stock price. Investors looking for management commentary, margin outlook, or guidance from the call will need to read the full transcript on the company's website.